[Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19].

V B Popova E A Antonova P M Hlyabova I S Rodyukova D N Alpenidze Yu V Drozdova K I Shamaeva S M Kryzhanovsky A S Tarakanova E V Yakubova A V Ivaschenko A A Ivaschenko

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)

According to the results of the study, the anxiolytic, antidepressant, antiasthenic and pro-cognitive effects of Aviandr were observed. An increase in the social activity of patients was observed.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
healthcare
prognostic factors
major depressive disorder
patient reported outcomes
bipolar disorder
anti inflammatory
replacement therapy